Results 181 to 190 of about 29,053 (244)
Treatment of an Aggressive Gonadotroph Pituitary Neuroendocrine Tumor With 177Lutetium DOTATATE Radionuclide Therapy. [PDF]
Gandhi C, Koumna S, Chik C.
europepmc +1 more source
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. [PDF]
Waked A+7 more
europepmc +1 more source
Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
Keunyoung Kim, Seong‐Jang Kim
openalex +2 more sources
Clinical characteristics and treatment patterns of patients with gastroenteropancreatic neuroendocrine neoplasia in Germany receiving peptide receptor radionuclide therapy: A real-world data registry-based study. [PDF]
von Hessert-Vaudoncourt C+10 more
europepmc +1 more source
Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors. [PDF]
Gujarathi R+4 more
europepmc +1 more source